The Cole Memo

On May 16, 2023, Metrc announced that Illinois planned to award the company a contract for its cannabis seed-to-sale tracking system.

According to a press release issued today by the State of Illinois, the state will transition to Metrc as its new seed-to-sale tracking system for medical and adult-use cannabis sometime this summer. The system will introduce RFID tags to track cannabis plants from seed to sale. Unlike other states, Illinois says cannabis businesses will not be charged for these tags, subject to certain restrictions. The press release also highlighted that Metrc will integrate with point-of-sale systems.

“We look forward to this new partnership with Metrc to ensure Illinois continues advancing the safest and most secure cannabis market,” said Erin Johnson, Illinois Cannabis Regulation Oversight Officer. “We are eager to work alongside the Metrc team to enhance compliance efficiencies, promote industry and consumer education, and bolster public safety to protect the integrity of the most equitable cannabis market in the country.” 

The state confirmed that BioTrack, the current seed-to-sale system, will remain in place until Metrc launches. According to the press release, Metrc provides seed-to-sale tracking in 27 jurisdictions and has training and implementation support services available for industry participants to help with the transition.

You can read the entire press release from the state below.

Press Release

Previous Coverage

I recently wrote about this topic and another cannabis-system transition that is expected in the future. You can read about it here.

Comment below with your thoughts and consider supporting my work!

You can support The Cole Memo with a one-time, monthly, or yearly contribution.

#242 – Trump makes a statement on rescheduling – The Cole Memo

In Episode 242, Cole breaks down President Trump’s latest comments on cannabis reclassification, comparing them to his earlier remarks from August and zooming in on what changed, especially the new emphasis on research. With reports swirling about possible timing, Cole reacts to the broader rumor mill, pulls in chatter from The Dales Report, and highlights how different corners of the industry are reading the tea leaves. Then the show opens up into a real conversation: rescheduling vs descheduling, the Farm Bill angle, 280E tax pressure, and the ongoing debate over whether state markets would survive a Schedule III world. Plus, a call-in from Brian brings the “people before profits” argument front and center, with a clear message that access matters more than labels like “hemp” or “marijuana.” Watch video version and read full show notes here: https://thecolememo.com/2025/12/15/e242/

1. #242 – Trump makes a statement on rescheduling 01:02:09
2. #241 – Cannabis Rescheduling Nears as ‘Scromiting’ Dominates Headlines 38:56
3. #240 – Patients Fight for Access, Closure of IL Cultivation Centers, Fresh Look, & More 01:44:10
4. #239 – A Look Inside the Veto Session and How Cannabis Policy Gets Made in Illinois 01:04:24
5. #238 – Live Q&A: Cole Breaks Down the Looming Federal Cannabis Ban 02:06:29